PDCD1, also known as PD-1, is a vital immune checkpoint gene for cancer immunotherapy, which interactions with PD-L1 negatively regulating adaptive immune response mainly by inhibiting the activity of effector T cells and enhancing the function of immunosuppressive Tregs (73). Here, PDCD1 is linked to cancer.